EMBA Elective Course B7768, Spring 2016
“Innovative Business Models in Global Healthcare”
Instructors:
Professor Lorraine Marchand ‘06
Llm2118@gsb.columbia.edu
Professor Mike Lovdal mike@mlovdal.com
Description
This course will examine innovation in the life sciences and health services industries and the new business models emerging in the U.S. and in global markets where healthcare infrastructure is still evolving.
Objectives

Analyze trends in life sciences and health services innovation

Study innovative business models in select country markets

Identify future opportunities for investment and career growth
Course Content
The course will cover specific subsectors in life sciences:

Pharmaceuticals

Biotechnology
 Medical devices

Diagnostics
And in health services:
 Healthcare technology
 Ambulatory and acute healthcare
 Healthcare financing

Integrated clinical and financial models
Cases will be drawn from a range of countries including the U.S., India, China, Haiti and the Middle East. The course will focus on ensuring students understand critical components of innovative healthcare business models including the:

Key drivers of change in life sciences and health services

Strategic challenges and opportunities to improve healthcare

Role of technology in innovation

Investment models and key actors

Role of various stakeholders, including consumers / patients

Cost, pricing and reimbursement

Role of government regulation

Legal and intellectual property
The class will utilize a consistent business model framework across sectors:

Opportunity Targeting
What customer / consumer market opportunities are being targeted?
Revenue / Profit Models
What revenue and profit models are being used to capture and grow value?
Value Proposition
What is the entity’s competitively differentiated value proposition for its customers / consumers?
How is the entity protecting its customer / consumer base and profits?
What are the scope of activities, assets and partners?
Strategic Control Scope
This framework will allow students to deepen their understanding of what drives and sustains innovation as countries explore creative ways to solve their healthcare problems around access, quality, cost and experience and how these imperatives are balanced with investment returns and risks.
Class Format and Instructors:
Class format will be lectures, readings, and case studies with senior executive guest speakers in every class possible. This course will be co-taught by former biopharmaceutical executive, Lorraine Marchand ‘06 and Mike Lovdal, former partner
Oliver Wyman with a focus on healthcare consulting.
Case Studies with Guest Speakers (illustrative):
Life Sciences:
 Pfizer (global pharmaceutical company)
 Casdin Capital Partner (life sciences investment firm)
 Syntimmune Inc. (biotechnology firm)
 Crystal Run Healthcare (multi-specialty practice)
 Medtronic

Arvinds Eye Hospital, India
 Cleveland Clinic (Abu Dhabi initiative)
Health Services:

Saint Boniface ( Haiti hospital and clinics)

Mt. Sinai Hospital (NYC Academic Medical Center)

UnitedHealthcare (national Health Insurer & services company)

One Medical Group (PE-backed primary care chain)

Hanger (retail provider of specialty healthcare)

AARP (national distributor of health insurance and services)